Your session is about to expire
← Back to Search
Brain Sensing Device for Stress Management
N/A
Waitlist Available
Led By Ivana T Croghan, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age or older at time of consent
Be older than 18 years old
Must not have
Currently (within 3 weeks) been enrolled in another clinical or research program (e.g. CAM) which intervenes on the patients' QOL, or stress
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether a wearable brain device can help physicians by measuring stress and QOL.
Who is the study for?
This trial is for practicing physicians at Mayo Clinic who are not pregnant, over 18 years old, able to participate fully and give informed consent. They must have a smartphone or tablet and no health conditions that would affect using the Muse S™ headband. Those with unstable medical/mental conditions, recent mindfulness training, drug trials participation, or other QOL/stress interventions can't join.
What is being tested?
The study tests if the Muse S™ brain sensing headband helps doctors during stressful times by tracking changes in their active and calm states. It aims to see if there's a link between these states and improvements in stress levels, sleep quality, resilience, and overall life quality.
What are the potential side effects?
Since this trial involves a non-invasive wearable device designed for wellness monitoring rather than medication or invasive therapy, significant side effects are not anticipated.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not joined any other clinical or research program affecting my quality of life or stress in the last 3 weeks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Duration adherence to intervention
Frequency adherence to intervention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Practicing PhysiciansExperimental Treatment1 Intervention
Practicing physicians at Mayo Clinic caring for patients during the COVID 19 pandemic will receive the Muse S™ Headband system, and will be asked to utilize it at least 4 times per week for a minimum of 10 minutes each time over a period of 3 months (12 weeks).
Find a Location
Who is running the clinical trial?
InteraXon, Inc.Industry Sponsor
4 Previous Clinical Trials
334 Total Patients Enrolled
Cambridge Brain SciencesIndustry Sponsor
2 Previous Clinical Trials
300 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,062,125 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The person did not report being pregnant at the time they gave consent.I can understand and agree to the study's procedures and risks.Do not have any health conditions that would prevent you from using the Muse-S system in the way it was intended, as determined by the clinical investigators.I have been practicing mindfulness regularly for the past 3 weeks.I can participate in all parts of this study.You have taken a drug that is not yet approved by the government in the last month.I have not joined any other clinical or research program affecting my quality of life or stress in the last 3 weeks.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Practicing Physicians
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger